
Driven by an unwavering commitment to advancing biological innovation, I am dedicated to pioneering the development of targeted anticancer therapies and organ regeneration strategies by discovering and characterizing novel metabolites from microorganisms - renowned for their potent bioactive compounds. My focus lies in identifying metabolites capable of selectively targeting cancer cells while promoting the repair of damaged tissues, offering a safer and more effective alternative to conventional therapies that often harm healthy organs. Furthermore, I strive to translate these groundbreaking discoveries into impactful clinical applications and transformative industrial solutions.